gefitinib - medicine shortage information

Back to ALL shortages and discontinuations    Back to CRITICAL shortages and discontinuations

If you are having difficulty obtaining a medicine that has been prescribed to you, talk to your doctor or pharmacist to discuss suitable options to continue your care.

More information about medicine shortages and how to access alternative medicines is available at the Medicine Shortages hub

Product details Supply Impact Dates Further Details
CIPLA GEFITINIB gefitinib 250 mg tablet blister pack
AUST R: 318433
Active ingredients:
gefitinib

Dosage form:
Tablet, film coated

Sponsor:
Cipla Australia Pty Ltd

Phone:
0396964413

From
08 Aug 2024
to
29 May 2025

Shortage status:
Resolved

Availability:
Available

Reason:
Manufacturing

IRESSA gefitinib 250 mg tablet blister pack
AUST R: 90010
Active ingredients:
gefitinib

Dosage form:
Tablet, film coated

Sponsor:
AstraZeneca Pty Ltd

Phone:
1800805342

From
23 Apr 2025
to
23 Apr 2025

Shortage status:
Resolved

Availability:
Available

Reason:
Commercial Changes / Commercial viability

Management action:
AstraZeneca has made the decision to continue to supply IRESSA in Australia